MétaCan
Menu
Back to cohort
Record W4414713462 · doi:10.3389/fphar.2025.1651909

Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice

2025· article· en· W4414713462 on OpenAlexaboutno aff
Mohitosh Biswas, Murshadul Alam Murad, Maliheh Ershadian, Chonlaphat Sukasem

Bibliographic record

VenueFrontiers in Pharmacology · 2025
Typearticle
Languageen
FieldMedicine
TopicDrug-Induced Adverse Reactions
Canadian institutionsnot available
Fundersnot available
KeywordsPharmacogenomicsPharmacogeneticsDosingAdverse effectClinical PracticeDrugAntibioticsClinical trial

Abstract

fetched live from OpenAlex

Adverse drug reactions (ADRs) are gradually becoming a concerning health threat worldwide in patients undergoing acute or chronic therapy. Antibiotics are the main drugs that cause immune-mediated ADRs, such as severe cutaneous adverse reactions (SCARs), allergic reactions, and organ-specific diseases, representing a significant threat to patient safety. In this review, we present the current genetic evidence available for antibiotic-related toxicities from a pharmacogenomics (PGx) perspective. We also explore the current state of PGx-based dosing recommendations and the factors limiting their widespread application in routine clinical practice. Through a systematic literature review, this study identified at least 12 antibiotic–gene pairs (amikacin–MT-RNR1, gentamicin–MT-RNR1, kanamycin–MT-RNR1, streptomycin–MT-RNR1, neomycin–MT-RNR1, tobramycin–MT-RNR1, isoniazid–NAT2, dapsone–HLA-B, co-trimoxazole–HLA-B, HLA-C, flucloxacillin–HLA-B, daunorubicin–SLC28A3, and doxorubicin–SLC28A3) with moderate to high Pharmacogenomics Knowledgebase (PharmGKB) evidence levels for toxicity. However, PGx-based dosing guidelines, as recommended by the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Dutch Pharmacogenetics Working Group (DPWG), and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), are currently available only for the following antibiotic–gene pairs: amikacin, gentamicin, kanamycin, streptomycin, neomycin, and tobramycin–MT-RNR1; flucloxacillin–HLA-B; dapsone–G6PD; nitrofurantoin–G6PD; and daunorubicin and doxorubicin–RARG, SLC28A3, and UGT1A6. Despite the established and growing genetic evidence for toxicity, particularly for Co-trimoxazole-induced SCARs by HLA-B and HLA-C, dapsone-induced SCARs by the HLA-B, and isoniazid-induced liver injury by the NAT2, insufficient approaches are being undertaken to translate these findings into routine clinical practice. The lack of validation of preliminary genetic associations, due to the scarcity of proper follow-up and large-scale replication, remains a key setback for PGx-based implementation of antibiotic therapy in clinical settings. More focused clinical studies, cost-effectiveness analyses, and polygenic risk score development are required to enable the PGx-based clinical use of antibiotics and optimize both safety and effectiveness in achieving precision medicine.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.017
metaresearch head score (Gemma)0.076
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.017
Threshold uncertainty score0.088

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0170.076
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.005
Bibliometrics0.0050.007
Science and technology studies0.0000.001
Scholarly communication0.0040.002
Open science0.0020.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.071
GPT teacher head0.458
Teacher spread0.387 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in PharmacologySame topicDrug-Induced Adverse ReactionsFrench-language works237,207